Piperacillin-Tazobactam Poses No Renal Risk in Adults With Sepsis

Comparing safety profiles of piperacillin-tazobactam and cefepime could help in choosing the safer empirical therapy for emergency department patients with suspected sepsis, suggests a new JAMA study.

Related Keywords

Tennessee ,United States ,Vanderbilt University ,Melbourne ,Victoria ,Australia ,Edwardt Qian , ,Department Of Infectious Diseases ,University Of Melbourne ,Vanderbilt University Medical Center ,Drug Administration ,Infectious Diseases ,Richmond Agitation Sedation Scale ,Sepsis ,Bloodstream Infections ,Antibiotics ,Igecycline ,Acute Kidney Injury Aki ,Acute Kidney Injury ,Eski ,Renal Failure ,Enal Insufficiency ,Idney Insufficiency ,Kidney Failure ,Intensive Care Unit Icu ,Intensive Care Unit ,Icu ,Intensive Care ,Kidneys ,Critical Illness ,Neurologic Complication ,